4 months ago
CYBN
AnalystsSumant KulkarniSumant Kulkarni's Stock Forecasts
AnalystsSumant Kulkarni
Analyst Ranking
Bottom 7%
#4142 out of 4426 analysts
Average Return
-14.03%
Win Rate
30%13 out of 44
Risk vs Reward
Poor
Good
Sumant Kulkarni's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Sage Therapeutics IncSAGE | +157.05% | $30.01 | $77.14 | 2020-04-08 - 2021-04-08 | Strong Buy |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | +126.10% | $22.49 | $50.85 | 2018-03-27 - 2019-03-27 | Strong Buy |
Alder Biopharmaceuticals IncALDR | +39.03% | $13.58 | $18.88 | 2019-03-14 - 2019-10-21 | Strong Buy |
Cybin IncCYBN | +33.12% | $0.31 | $0.41 | 2023-09-01 - 2023-12-08 | Strong Buy |
Biogen IncBIIB | +30.27% | $221.30 | $288.28 | 2022-02-07 - 2023-02-06 | Strong Buy |
Sumant Kulkarni Analyst Color
Get additional color on Sumant Kulkarni's coverage of popular stocks
4 months ago
SAGE
5 months ago
CYBN
Sumant Kulkarni's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $150.00 | +27.90% | Reiterates | 4 days ago |
Zevra Therapeutics IncZVRA | 3 | Strong Buy | $20.00 | +293.70% | Reiterates | 3 months ago |
Cybin IncCYBN | 3 | Strong Buy | $5.00 | +1,107.73% | Reiterates | 3 months ago |
Compass Pathways PLCCMPS | 1 | Strong Buy | $50.00 | +672.80% | Maintains | 4 months ago |
Zynerba Pharmaceuticals IncZYNE | 2 | Hold | $1.11 | -14.62% | Downgrades | 4 months ago |
Bioxcel Therapeutics IncBTAI | 3 | Strong Buy | $20.00 | +530.91% | Maintains | 4 months ago |
Sage Therapeutics IncSAGE | 3 | Hold | $21.00 | +4.95% | Downgrades | 4 months ago |
Acadia Pharmaceuticals IncACAD | 4 | Strong Buy | $38.00 | +81.12% | Maintains | 4 months ago |
Biogen IncBIIB | 9 | Strong Buy | $350.00 | +46.27% | Maintains | 6 months ago |
Voyager Therapeutics IncVYGR | 2 | Strong Buy | $14.00 | +80.41% | Maintains | 7 months ago |
Stoke Therapeutics IncSTOK | 1 | Strong Buy | $24.00 | +403.14% | Assumes | 7 months ago |
Intra Cellular Therapies IncITCI | 1 | Strong Buy | $98.00 | +62.55% | Maintains | 8 months ago |
Cara Therapeutics IncCARA | 2 | Strong Buy | $25.00 | +1,900.00% | Maintains | 9 months ago |
Clene IncCLNN | 2 | Strong Buy | $6.00 | N/A | Maintains | a year ago |
Gh Research PLCGHRS | 2 | Strong Buy | $41.00 | N/A | Maintains | 2 years ago |
Quince Therapeutics IncQNCX | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 3 | Strong Buy | $150.00 | N/A | Maintains | 2 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Strong Buy | $20.00 | N/A | Maintains | 5 years ago |
Avexis IncAVXS | 1 | Hold | $120.00 | N/A | Maintains | 6 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | N/A | N/A | Upgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.